Related Experiment Video
Updated: Jun 25, 2026

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
Published on: July 14, 2021
Myocardial fibrosis and ventricular remodeling in severe chronic aortic regurgitation
Nelson Elias1, Flávio Tarasoutchi, Guilherme Sobreira Spina
1Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
Insights
In patients with chronic severe aortic regurgitation, myocardial fibrosis was elevated but did not correlate with clinical outcomes or left ventricular remodeling. This suggests limited fibrosis may not impact complications in these patients.
Area of Science:
- Cardiology
- Cardiovascular Pathology
- Cardiac Surgery
Background:
- Symptomatic chronic aortic regurgitation (AR) causes significant left ventricular (LV) remodeling.
- The role of interstitial fibrosis in AR pathophysiology is not well understood.
Purpose of the Study:
- To evaluate the extent of myocardial fibrosis in patients with chronic severe aortic regurgitation.
Main Methods:
- Twenty-eight symptomatic AR patients underwent echocardiography and cardiopulmonary testing.
- Myocardial fibrosis volume fraction (MFV) was quantified via endomyocardial biopsy during surgery.
- Histopathology was compared to a nine-patient control group.
Main Results:
- Patients with AR showed significantly higher MFV compared to controls (3.47% vs 0.82%, p=0.001).
- No correlation was found between LV fibrosis and LV dimensions, ejection fraction, or maximal oxygen consumption.
- LV diameters significantly reduced post-surgery; functional capacity remained similar.
Conclusions:
- Limited myocardial fibrosis in significant symptomatic AR is not associated with clinical, echocardiographic, or functional complications.
- Further research may clarify the prognostic significance of varying fibrosis levels in AR.
Background:
Significant symptomatic chronic aortic regurgitation (AR) leads to considerable left ventricular remodeling at the expense of myocyte hypertrophy and extracellular matrix remodeling. The relevance of interstitial fibrosis concentration in these patients is unknown. We analyzed the degree of fibrosis in the left ventricle (LV) in symptomatic patients with AR submitted to surgical treatment, and its relationship with functional and anatomical characteristics.
Objective:
To evaluate myocardial fibrosis in chronic severe aortic regurgitation.
Methods:
Twenty-eight patients with chronic symptomatic AR (16 with normal LV function and 12 with LV dysfunction) were selected and assessed pre- and postoperatively by echocardiography. Functional capacity was measured using maximal oxygen consumption (VO2max) through the cardiopulmonary test. Myocardial fibrosis volume fraction (MFV) was quantified through endomyocardial biopsy performed in all patients during surgery. We compared the histopathologic results with a nine-patient control group.
Results:
The mean age was 39 +/- 12 years, 75% of the patients were male, and the rheumatic etiology accounted for 84% of the cases. Twenty-five patients remained in FC l and ll at the end of the study, and there was a significant reduction of the LV diameters between the preoperative and late postoperative timepoints. Three deaths occurred but they were not related to postoperative ventricular dysfunction. The parameters of the cardiopulmonary test were similar between pre- and postoperative timepoints. MFV in patients with AR was significantly higher than in the control group (3.47 +/- 1.9% vs 0.82 +/- 0.96%, respectively, p=0.001). There was no statistical correlation among LV fibrosis and LV diameters, LVEF and MVO2.
Conclusion:
In patients with significant symptomatic AR, the presence of limited myocardial fibrosis was not associated with clinical, echocardiographic or functional complications.
More Related Videos
Related Concept Videos
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction
Rheumatic Heart Disease I: Introduction

